Power of pee: Urine‐derived stem cells in urological disorders

Abstract

Given that urine‐derived stem cells (USCs) originate from the urinary tract system, they hold great potential for treating urological disorders. USCs have several advantages over other types of stem cells, such as easy and noninvasive collection, and abundant supply. USCs can differentiate into different types of cells. This makes them a potential source of cells for tissue engineering and regenerative medicine in the field of urology. In animal models, USCs or USC‐derived exosomes regenerate damaged tissues in the treatment of various urological disorders such as urinary incontinence, bladder dysfunction, interstitial cystitis, urethra injury erectile dysfunction, and kidney injury via multiple differentiation potential, angiogenesis, anti‐inflammatory, paracrine effects, and immune modulation capability. Overall, the use of USCs in urological disorders is a rapidly developing field, and ongoing research is needed to fully understand their potential applications. However, the early results are promising and suggest that USCs could become a valuable cell source for the treatment of various urological disorders in the future.

Keywords

cell therapy / stem cells / tissue regeneration / urine / urological diseases

References

[1] Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008 Nov; 180 (5): 2226– 33.

[2] Bharadwaj S, Liu G, Shi Y, Markert C, Andersson KE, Atala A, et al. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011 Aug; 17 (15–16): 2123– 32.

[3] Bharadwaj S, Liu G, Shi Y, Wu R, Yang B, He T, et al. Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells. 2013 Sep; 31 (9): 1840– 56.

[4] Huang RL, Li Q, Ma JX, Atala A, Zhang Y. Body fluid‐derived stem cells: an untapped stem cell source in genitourinary regeneration. 2014; 5 (5): 112.

[5] Perin L, Sedrakyan S, Da Sacco S, De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol. 2008; 86: 85- 99.

[6] de Sousa EB, Casado PL, Moura Neto V, Duarte ME, Aguiar DP. Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives. Stem Cell Res Ther. 2014; 5 (5): 112.

[7] Zhang S, Muneta T, Morito T, Mochizuki T, Sekiya I. Autologous synovial fluid enhances migration of mesenchymal stem cells from synovium of osteoarthritis patients in tissue culture system. J Orthop Res. 2008 Oct; 26 (10): 1413- 8.

[8] Hosseini SM, Talaei-Khozani T, Sani M, Owrangi B. Differentiation of human breast-milk stem cells to neural stem cells and neurons. Neurol Res Int. 2014; 2014: 1- 8.

[9] Kawano Y, Takaue Y, Watanabe T, Abe T, Okamoto Y, Iwai A, et al. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors. Cancer Res. 1999 Jul 15; 59 (14): 3321- 4.

[10] Luz-Crawford P, Torres MJ, Noël D, Fernandez A, Toupet K, Alcayaga-Miranda F, et al. The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases. Stem Cells. 2016 Feb; 34 (2): 456- 69.

[11] Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant. 2008; 17 (3): 303- 11.

[12] Fernandez CV, Gordon K, Van den Hof M, Taweel S, Baylis F. Knowledge and attitudes of pregnant women with regard to collection, testing and banking of cord blood stem cells. Can Med Assoc J. 2003; 168 (6): 695- 8.

[13] Yang H, Chen B, Deng J, Zhuang G, Wu S, Liu G, et al. Characterization of rabbit urine‐derived stem cells for potential application in lower urinary tract tissue regeneration. Cell Tissue Res. 2018 Nov 1; 374 (2): 303- 15.

[14] Liu Y, Ma W, Liu B, Wang Y, Chu J, Xiong G, et al. Urethral reconstruction with autologous urine‐derived stem cells seeded in three‐dimensional porous small intestinal submucosa in a rabbit model. Stem Cell Res Ther. 2017 Mar 9; 8 (1): 63.

[15] Qin D, Long T, Deng J, Zhang Y. Urine-derived stem cells for potential use in bladder repair. Stem Cell Res Ther. 2014; 5 (3): 69.

[16] Pei M, Li J, Zhang Y, Liu G, Wei L. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014 May; 356 (2): 391- 403.

[17] Ouyang B, Sun X, Han D, Chen S, Yao B, Gao Y, et al. Human urine-derived stem cells alone or genetically-modified with FGF2 improve type 2 diabetic erectile dysfunction in a rat model. PLoS One. 2014; 9 (3): e92825.

[18] Liu G, Wang X, Sun X, Deng C, Atala A, Zhang Y. The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude mice. Biomaterials. 2013 Nov; 34 (34): 8617- 29.

[19] Lang R, Liu G, Shi Y, Bharadwaj S, Leng X, Zhou X, et al. Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One. 2013; 8 (1): e53980.

[20] Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc. 2012 Dec; 7 (12): 2080- 9.

[21] Liu G, Pareta RA, Wu R, Shi Y, Zhou X, Liu H, et al. Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors. Biomaterials. 2013 Jan; 34 (4): 1311- 26.

[22] Wu S, Wang Z, Bharadwaj S, Hodges SJ, Atala A, Zhang Y. Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol. 2011 Aug; 186 (2): 640- 7.

[23] Wu S, Liu Y, Bharadwaj S, Atala A, Zhang Y. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials. 2011 Feb; 32 (5): 1317- 26.

[24] Bodin A, Bharadwaj S, Wu S, Gatenholm P, Atala A, Zhang Y. Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials. 2010 Dec; 31 (34): 8889- 901.

[25] Erichsen L, Thimm C, Bohndorf M, Rahman MS, Wruck W, Adjaye J. Activation of the renin-angiotensin system disrupts the cytoskeletal architecture of human urine-derived podocytes. Cells. 2022 Mar 24; 11 (7): 1095.

[26] Wan Q, Xiong G, Liu G, Shupe TD, Wei G, Zhang D, et al. Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction. Stem Cell Res Ther. 2018; 9 (1): 304- 14.

[27] Wu RP, Soland M, Liu G, Shi YA, Bharadwaj S, Atala A, et al. Immunomodulatory properties of urine derived stem cells. In: The 3rd Annual Regenerative Medicine Foundation Conference 2012 Abstract Book, October 18-19; Charlotte, NC, USA. 2012.

[28] Guan X, Mack DL, Moreno CM, Strande JL, Mathieu J, Shi Y, et al. Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery. Stem Cell Res. 2014 Mar; 12 (2): 467- 80.

[29] Liu Y, Zheng Y, Li S, Xue H, Schmitt K, Hergenroeder GW, et al. Human neural progenitors derived from integration-free iPSCs for SCI therapy. Stem Cell Res. 2017 Mar; 19: 55- 64.

[30] Gao WW, Zheng J, Yun W, Kang PJ, Park G, Song G, et al. Generation of induced nephron progenitor-like cells from human urine-derived cells. Int J Mol Sci. 2021 Dec 15; 22 (24): 13449.

[31] Boonkaew B, Thummavichit W, Netsrithong R, Vatanashevanopakorn C, Pattanapanyasat K, Wattanapanitch M. Establishment of an integration-free induced pluripotent stem cell line (MUSIi005-A) from exfoliated renal epithelial cells. Stem Cell Res. 2018 Jul; 30: 34- 7.

[32] Lazzeri E, Ronconi E, Angelotti ML, Peired A, Mazzinghi B, Becherucci F, et al. Human urine-derived renal progenitors for personalized modeling of genetic kidney disorders. J Am Soc Nephrol. 2015 Aug; 26 (8): 1961- 74.

[33] Chun SY, Kim HT, Lee JS, Kim MJ, Kim BS, Kim BW, et al. Characterization of urine-derived cells from upper urinary tract in patients with bladder cancer. Urology. 2012 May; 79 (5): 1186.e1- e7.

[34] Zhou J, Wang X, Zhang S, Gu Y, Yu L, Wu J, et al. Generation and characterization of human cryptorchid‐specific induced pluripotent stem cells from urine. Stem Cells Dev. 2013 Mar 1; 22 (5): 717- 25.

[35] Afzal MZ, Strande JL. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp. 2015; 95: 52032.

[36] Guan J, Zhang J, Guo S, Zhu H, Zhu Z, Li H, et al. Human urine-derived stem cells can be induced into osteogenic lineage by silicate bioceramics via activation of the Wnt/β-catenin signaling pathway. Biomaterials. 2015 Jul; 55: 1- 11.

[37] Guan J, Zhang J, Li H, Zhu Z, Guo S, Niu X, et al. Human urine derived stem cells in combination with β-TCP can be applied for bone regeneration. PLoS One. 2015; 10 (5): e0125253.

[38] Jiang ZZ, Liu YM, Niu X, Yin JY, Hu B, Guo SC, et al. Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats. Stem Cell Res Ther. 2016; 7 (1): 24.

[39] Jouni M, Si-Tayeb K, Es-Salah-Lamoureux Z, Latypova X, Champon B, Caillaud A, et al. Toward personalized medicine: using cardiomyocytes differentiated from urine-derived pluripotent stem cells to recapitulate electrophysiological characteristics of type 2 long QT syndrome. J Am Heart Assoc. 2015 Sep; 4 (9): e002159.

[40] Kang HS, Choi SH, Kim BS, Choi JY, Park GB, Kwon TG, et al. Advanced properties of urine derived stem cells compared to adipose tissue derived stem cells in terms of cell proliferation, immune modulation and multi differentiation. J Korean Med Sci. 2015 Dec; 30 (12): 1764- 76.

[41] Lee JN, Chun SY, Lee HJ, Jang YJ, Choi SH, Kim DH, et al. Human urine-derived stem cells seeded surface modified composite scaffold grafts for bladder reconstruction in a rat model. J Korean Med Sci. 2015; 30 (12): 1754- 63.

[42] Nersesyan A, Kundi M, Fenech M, Bolognesi C, Misik M, Wultsch G, et al. Micronucleus assay with urine derived cells (UDC): a review of its application in human studies investigating genotoxin exposure and bladder cancer risk. Mutat Res Rev Mutat Res. 2014 Oct–Dec; 762: 37- 51.

[43] Zhang SZ, Li HF, Ma LX, Qian WJ, Wang ZF, Wu ZY. Urine-derived induced pluripotent stem cells as a modeling tool for paroxysmal kinesigenic dyskinesia. Biol Open. 2015; 4 (12): 1744- 52.

[44] Guan J, Zhang J, Zhu Z, Niu X, Guo S, Wang Y, et al. Bone morphogenetic protein 2 gene transduction enhances the osteogenic potential of human urine-derived stem cells. Stem Cell Res Ther. 2015 Jan 7; 6 (1): 5.

[45] Oliveira Arcolino F, Tort Piella A, Papadimitriou E, Bussolati B, Antonie DJ, Murray P, et al. Human urine as a noninvasive source of kidney cells. Stem Cells Int. 2015; 2015: 1- 7.

[46] Qin H, Zhu C, An Z, Jiang Y, Zhao Y, Wang J, et al. Silver nanoparticles promote osteogenic differentiation of human urine-derived stem cells at noncytotoxic concentrations. Int J Nanomed. 2014; 9: 2469- 78.

[47] Wang C, Hei F, Ju Z, Yu J, Yang S, Chen M. Differentiation of urine-derived human induced pluripotent stem cells to alveolar type II epithelial cells. Cell Reprogram. 2016 Feb; 18 (1): 30- 6.

[48] Fu Y, Guan J, Guo S, Guo F, Niu X, Liu Q, et al. Human urine-derived stem cells in combination with polycaprolactone/gelatin nanofibrous membranes enhance wound healing by promoting angiogenesis. J Transl Med. 2014 Oct 2; 12 (1): 274.

[49] Guan JJ, Niu X, Gong FX, Hu B, Guo SC, Lou YL, et al. Biological characteristics of human-urine-derived stem cells: potential for cell-based therapy in neurology. Tissue Eng Part A. 2014 Jul; 20(13–14): 1794- 806.

[50] Xue Y, Cai X, Wang L, Liao B, Zhang H, Shan Y, et al. Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS One. 2013; 8 (8): e70573.

[51] Jia B, Chen S, Zhao Z, Liu P, Cai J, Qin D, et al. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells. Life Sci. 2014 Jul 11; 108 (1): 22- 9.

[52] Chen Y, Luo R, Xu Y, Cai X, Li W, Tan K, et al. Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine. Rheumatol Int. 2013 Aug; 33 (8): 2127- 34.

[53] Benda C, Zhou T, Wang X, Tian W, Grillari J, Tse H‐F, et al. Urine as a source of stem cells. Research support, non‐U.S. Gov't review. Adv Biochem Eng Biotechnol. 2013; 129: 19- 32.

[54] Zhou T, Benda C, Duzinger S, Huang Y, Li X, Li Y, et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol. 2011 Jul; 22 (7): 1221- 8.

[55] Shi YA, Liu GH, Bharadwaj S, Atala A, Zhang Y. Urine derived stem cells with high telomerase activity for cell based therapy in urology. J Urol. 2012; 187 (Suppl 4): e302.

[56] Peters KM, Dmochowski RR, Carr LK, Robert M, Kaufman MR, Sirls LT, et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014 Aug; 192 (2): 469- 76.

[57] Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, Jach R, Uhl T, Basta A, et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Neurourol Urodyn. 2014 Mar; 33 (3): 324- 30.

[58] Zhuang J, Gao P, Chen H, Fang Z, Zheng J, Zhu D, et al. Extracellular vesicles from human urine-derived stem cells merged in hyaluronic acid ameliorate erectile dysfunction in type 2 diabetic rats by glans administration. Andrology. 2022 Nov; 10 (8): 1673- 86.

[59] Ouyang B, Xie Y, Zhang C, Deng C, Lv L, Yao J, et al. Extracellular vesicles from human urine-derived stem cells ameliorate erectile dysfunction in a diabetic rat model by delivering proangiogenic microRNA. Sex Med. 2019 Jun; 7 (2): 241- 50.

[60] Yang Q, Chen W, Han D, Zhang C, Xie Y, Sun X, et al. Intratunical injection of human urine-derived stem cells derived exosomes prevents fibrosis and improves erectile function in a rat model of Peyronie's disease. Andrologia. 2020 Dec; 52 (11): e13831.

[61] Akiyama Y, Luo Y, Hanno PM, Maeda D, Homma Y. Interstitial cystitis/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int J Urol. 2020 Jun; 27 (6): 491- 503.

[62] Kwon WA. Animal model of interstitial cystitis/bladder pain syndrome. Int Neurourol J. 2018 Jan; 22 (Suppl 1): S1- 2.

[63] Chung JW, Chun SY, Lee EH, Ha YS, Lee JN, Song PH, et al. Verification of mesenchymal stem cell injection therapy for interstitial cystitis in a rat model. PLoS One. 2019; 14 (12): e0226390.

[64] Li J, Luo H, Dong X, Liu Q, Wu C, Zhang T, et al. Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model. Stem Cell Res Ther. 2017 May 8; 8 (1): 107.

[65] Otani Y, Ichii O, Otsuka-Kanazawa S, Chihara M, Nakamura T, Kon Y. MRL/MpJ-Fas(lpr) mice show abnormalities in ovarian function and morphology with the progression of autoimmune disease. Autoimmunity. 2015; 48 (6): 402- 11.

[66] Bao Y-W, Yuan Y, Chen J-H, Lin WQ. Kidney disease models: tools to identify mechanisms and potential therapeutic targets. Zool Res. 2018; 39 (2): 72- 86.

[67] Gao WW, Chun SY, Kim BS, Ha YS, Lee JN, Lee EH, et al. Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy. Biochem Biophys Res Commun. 2022; Nov 12; 629: 128- 34.

[68] Zhang C, George SK, Wu R, Thakker PU, Abolbashari M, Kim TH, et al. Reno-protection of urine-derived stem cells in a chronic kidney disease rat model induced by renal ischemia and nephrotoxicity. Int J Biol Sci. 2020; 16 (3): 435- 46.

[69] Wu C, Chen L, Huang Y, Huang Y, Parolini O, Zhong Q, et al. Comparison of the proliferation and differentiation potential of human urine-, placenta decidua basalis-, and bone marrow-derived stem cells. Stem Cells Int. 2018; 2018: 1- 11.

[70] Wu AK, Zhang X, Wang J, Ning H, Zaid U, Villalta JD, et al. Treatment of stress urinary incontinence with low‐intensity extracorporeal shock wave therapy in a vaginal balloon dilation induced rat model. Transl Androl Urol. 2018; 7 (Suppl 1): S7- 16.

[71] Li Y, Liu C, Li B, Hong S, Min J, Hu M, et al. Electrical stimulation activates calpain 2 and subsequently upregulates collagens via the integrin β1/TGF-β1 signaling pathway. Cell Signal. 2019 Jul; 59: 141- 51.

[72] Tang J, Liu C, Li B, Hong S, Li Q, Wang L, et al. Protective Role of nuclear factor erythroid-2-related factor 2 against mechanical trauma-induced apoptosis in a vaginal distension-induced stress urinary incontinence mouse model. Oxid Med Cell Longevity. 2019; 2019: 1- 10.

[73] Yang B, Li M, Lei H, Xu Y, Li H, Gao Z, et al. Low intensity pulsed ultrasound influences the myogenic differentiation of muscle satellite cells in a stress urinary incontinence rat model. Urology. 2019 Jan; 123: 297e1- e8.

[74] Liu G, Wu R, Yang B, Shi Y, Deng C, Atala A, et al. A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo. Acta Biomater. 2020 Apr 15; 107: 50- 64.

[75] Liu G, Wu R, Yang B, Deng C, Lu X, Walker SJ, et al. Human urine-derived stem cell differentiation to endothelial cells with barrier function and nitric oxide production. Stem Cells Transl Med. 2018 Sep; 7 (9): 686- 98.

[76] Wu R, Huang C, Wu Q, Jia X, Liu M, Xue Z, et al. Exosomes secreted by urine-derived stem cells improve stress urinary incontinence by promoting repair of pubococcygeus muscle injury in rats. Stem Cell Res Ther. 2019 Mar 8; 10 (1): 80.

[77] Sokolakis I, Dimitriadis F, Psalla D, Karakiulakis G, Kalyvianakis D, Hatzichristou D. Effects of low-intensity shock wave therapy (LiST) on the erectile tissue of naturally aged rats. Int J Impotence Res. 2019 May; 31 (3): 162- 9.

[78] Yang S, Zhang Y, Lyu X, Gu Y, Zhang G, Liu P, et al. The association between FGF21 and diabetic erectile dysfunction: evidence from clinical and animal studies. Front Endocrinol. 2022; 13: 13874796.

[79] Galhom RA, Korayem HE, Ibrahim MA, Abd-Eltawab Tammam A, Khalifa MM, Rashwan EK, et al. Urine-derived stem cells versus their lysate in ameliorating erectile dysfunction in a rat model of type 2 diabetes. Front Physiol. 2022; 13: 854949.

[80] Xu Y, Shen Z, Liu G, Liu B, Hua X, Xiang Y, et al. Urethral reconstruction using everted saphenous vein graft in a rabbit model: one-year outcomes. Urol Int. 2017; 99 (1): 110- 7.

[81] Håkansson J, Jenndahl L, Simonsson S, Johansson ME, Larsson K, Strehl R, et al. De‐and recellularized urethral reconstruction with autologous buccal mucosal cells implanted in an ovine animal model. Biomed Eng Biomed Tech. 2023 Apr 3

[82] Aizawa N, Igawa Y. Pathophysiology of the underactive bladder. Investig Clin Urol. 2017 Dec; 58 (2): S82- 9.

[83] Liu G, Daneshgari F. Diabetic bladder dysfunction. Chin Med J. 2014; 127 (7): 1357- 64.

[84] Song YT, Li YQ, Tian MX, Hu JG, Zhang XR, Liu PC, et al. Application of antibody-conjugated small intestine submucosa to capture urine-derived stem cells for bladder repair in a rabbit model. Bioactive Mater. 2022 Aug; 14: 443- 55.

[85] Tu M, Wang R, Zhu P, Wang Q, Sun B, Lu K, et al. Human urine-derived stem cells improve partial bladder outlet obstruction in rats: preliminary data and microRNA-mRNA expression profile. Stem Cell Rev Rep. 2022 Oct; 18 (7): 2403- 13.

[86] Yang Q, Chen X, Zheng T, Han D, Zhang H, Shi Y, et al. Transplantation of human urine-derived stem cells transfected with pigment epithelium-derived factor to protect erectile function in a rat model of cavernous nerve injury. Cell Transplant. 2016 Nov; 25 (11): 1987- 2001.

[87] Zhang C, Luo D, Li T, Yang Q, Xie Y, Chen H, et al. Transplantation of human urine-derived stem cells ameliorates erectile function and cavernosal endothelial function by promoting autophagy of corpus cavernosal endothelial cells in diabetic erectile dysfunction rats. Stem Cells Int. 2019; 2019: 1- 13.

[88] Yang Q, Chen W, Han D, Zhang C, Xie Y, Sun X, et al. Intratunical injection of human urine-derived stem cells derived exosomes prevents fibrosis and improves erectile function in a rat model of Peyronie's disease. Andrologia. 2020 Sep 28; 52: e13831.

[89] Xiong G, Tao L, Ma WJ, Gong MJ, Zhao L, Shen LJ, et al. Urine-derived stem cells for the therapy of diabetic nephropathy mouse model. Eur Rev Med Pharmacol Sci. 2020 Feb; 24 (3): 1316- 24.

RIGHTS & PERMISSIONS

2023 2023 The Authors. UroPrecision published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.